Global Nutrigenomics Market is valued at approximately USD 435.7 Million in 2022 and is anticipated to grow with a healthy growth rate of more than 17.2% during the forecast period 2023-2030. Nutrigenomics is the study of how nutrients can affect gene expression, providing understanding of how dietary factors can impact an individual's genetic makeup and its connection to health and disease. The Global Nutrigenomics Market is growing continuously due to factors such as a rising number of research activities, a growing prevalence of chronic diseases and a growing geriatric population.

Nutrigenomics provides insights related to individual genetic differences interacting with dietary elements, providing understanding into the development of personalized dietary recommendations for addressing issues related to chronic diseases such as Diabetes, Cancer and more. According to the International Diabetes Federation, India is home to over 77 million adults with diabetes, and this number is expected to increase to 134 million by 2045. The prevalence of diabetes in India is also on the rise, with an estimated 8.9% of the adult population affected by the disease. The continuous increase in the number of diabetic patients in India as well as in other parts of the world led to a simultaneous growth of the Global Nutrigenomics Market. Moreover, the growing trend of personalized diets and increasing focus on healthy lifestyles are opportunities for the Global Nutrigenomics Market. However, the high cost of Nutrigenomics hinders the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Nutrigenomics Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022. The regional market is expected to grow in the coming years due to the introduction and advancement of direct-to-consumer nutrigenomics kits, as well as the rising consumption of specialized food and diets in the area. Asia Pacific is expected to grow significantly over the forecast period, owing to the increased demand for functional foods and beverages led to a increased usage of nutrigenomic techniques. Japan, being the largest consumer of functional foods in the region, is expected to drive the market in the coming years.

Major market player included in this report are:
Vitagene
Mapmygenome
Gini Health
GeneOmbio Technologies
Nutrigenomix
23andMe Inc.
DNAfit
GX Sciences.
Xcode Life
Gene Smart
Recent Developments in the Market:
In Oct 2021,23 and Me Holding Co. purchased Lemonaid Health, a telehealth platform that allows patients to access licensed medical professionals for treatment and consultation for a variety of common conditions, as well as telehealth consultations for specific 23 and Me genetic reports.
In May 2023, Xcode Life introduced the most extensive Gene Nutrition test in India, encompassing almost 50 nutritional factors. These factors include the way macronutrients (carbs, protein, and fats) are broken down based on genotype, the likelihood of vitamin and mineral deficiencies, eating habits, managing weight through nutrition, taste preferences, diet reactions, and food sensitivities.
Global Nutrigenomics Market Report Scope:
Historical Data -2020 - 2021
Base Year for Estimation - 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered -Product Type, Applications, End Users, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Reagents and Kits
Services
By Applications:
Obesity
Diabetes
Cardiovascular Diseases
Cancer Research
By End Users:
Online Platforms
Hospitals and Clinics
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa